91 related articles for article (PubMed ID: 20026648)
41. STAT3: a central mediator of pulmonary fibrosis?
Prêle CM; Yao E; O'Donoghue RJ; Mutsaers SE; Knight DA
Proc Am Thorac Soc; 2012 Jul; 9(3):177-82. PubMed ID: 22802294
[TBL] [Abstract][Full Text] [Related]
42. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
43. Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis.
Järvinen PM; Myllärniemi M; Liu H; Moore HM; Leppäranta O; Salmenkivi K; Koli K; Latonen L; Band AM; Laiho M
J Cell Physiol; 2012 Jun; 227(6):2605-12. PubMed ID: 21882188
[TBL] [Abstract][Full Text] [Related]
44. Yin Yang-1(YY-1) expression in idiopathic pulmonary fibrosis.
Margaritopoulos GA; Antoniou KM; Soufla G; Vassalou E; Spandidos DA; Siafakas NM
J Recept Signal Transduct Res; 2011 Apr; 31(2):188-91. PubMed ID: 21385102
[TBL] [Abstract][Full Text] [Related]
45. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
[TBL] [Abstract][Full Text] [Related]
46. Antioxidant therapy for idiopathic pulmonary fibrosis. A promising therapeutic prospect.
Tomioka H
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):83-4. PubMed ID: 20560287
[No Abstract] [Full Text] [Related]
47. Method for Investigating Fibroblast Durotaxis.
Kadry H; Lagares D; Al-Hilal TA
Methods Mol Biol; 2021; 2299():227-236. PubMed ID: 34028747
[TBL] [Abstract][Full Text] [Related]
48. Releasing Tensin.
Horowitz JC
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):417-418. PubMed ID: 28362149
[No Abstract] [Full Text] [Related]
49. The Idiopathic Pulmonary Fibrosis Cell Atlas.
Neumark N; Cosme C; Rose KA; Kaminski N
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L887-L893. PubMed ID: 32996785
[No Abstract] [Full Text] [Related]
50. Putting the brakes on age-related idiopathic pulmonary fibrosis: can Nox4 inhibitors suppress IPF?
Turn CS; Lockey RF; Kolliputi N
Exp Gerontol; 2015 Mar; 63():81-2. PubMed ID: 25668226
[No Abstract] [Full Text] [Related]
51. MMP28 in Idiopathic Pulmonary Fibrosis: Beyond the Extracellular Matrix.
Atamas SP
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):5-6. PubMed ID: 29957054
[No Abstract] [Full Text] [Related]
52. Idiopathic pulmonary fibrosis: a shot through the heart?
Zisman DA; Kawut SM
Am J Respir Crit Care Med; 2008 Dec; 178(12):1192-3. PubMed ID: 19050202
[No Abstract] [Full Text] [Related]
53. Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis.
Stewart ID; Nanji H; Figueredo G; Fahy WA; Maher TM; Ask AJ; Maharaj S; Ask K; Kolb M; Jenkins GR
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33766945
[TBL] [Abstract][Full Text] [Related]
54. Idiopathic Pulmonary Fibrosis: A Systemic Disease?
Man L; Hong P
Chin Med J (Engl); 2017 Sep; 130(17):2140-2141. PubMed ID: 28836568
[No Abstract] [Full Text] [Related]
55. Fibroblast-Matrix Cross-Talk in Idiopathic Pulmonary Fibrosis: Cross-Links at the Crossroads.
Bitterman P
Am J Respir Cell Mol Biol; 2018 May; 58(5):547-548. PubMed ID: 29714627
[No Abstract] [Full Text] [Related]
56. Lung disease: resetting the redox balance in lung fibrosis.
Bray N
Nat Rev Drug Discov; 2014 Jun; 13(6):415. PubMed ID: 24833297
[No Abstract] [Full Text] [Related]
57. The battlefield of rare diseases: where uncommon insights are common.
Gahl WA
Sci Transl Med; 2012 Oct; 4(154):154ed7. PubMed ID: 23035044
[No Abstract] [Full Text] [Related]
58. Quercetin in Idiopathic Pulmonary Fibrosis: Another Brick in the Senolytic Wall.
Sellarés J; Rojas M
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):3-4. PubMed ID: 30211613
[No Abstract] [Full Text] [Related]
59. Gene expression phenotypes of oncogenic signaling pathways.
Huang ES; Black EP; Dressman H; West M; Nevins JR
Cell Cycle; 2003; 2(5):415-7. PubMed ID: 12963829
[No Abstract] [Full Text] [Related]
60. Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis.
Cui H; Xie N; Jiang D; Banerjee S; Ge J; Sanders YY; Liu G
Am J Respir Cell Mol Biol; 2019 Oct; 61(4):492-500. PubMed ID: 30943369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
